Loading...
13 Asia Synthetic Compounds Reports
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Apotex, Fresenius, Mylan, Pfizer
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter, Bristol-Myers Squibb, Merck, Grifols (Biotest AG), Thermo Fisher Scientific
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Merck, MAHENDRA CHEMICALS, Nortec Qumica, Cirondrugs
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Covaris, IDEX, Abbvie, Ascendia Pharmaceuticals, Owen Biosciences
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Galderma, LG Chem, Syner-Med, Anika Therapeutics, Zydus Group
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Roche, Thermo Fisher Scientific, Johnson & Johnson, Pfizer
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Apothecon Pharmaceuticals, Manus Aktteva Biopharma, Recordati Rare Diseases, Civentichem, Dipharma Francis
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Novo Nordisk, Eli Lilly and Company, Novartis, Merck
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck, Takeda Pharmaceuticals, Biovision, Promega, Tocris Bioscience
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Amgen, Bristol-Myers Squibb, GlaxoSmithKline, AstraZeneca
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Merck, Morepen, Teva Pharmaceutical Industries, Cipla, Sanofi
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Evolus, Abbvie, Merz Pharma, Ipsen, Galderma
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: SARIA International GmbH (Bioiberica S.A.U), Roche, Merck, Synutra, Lesaffre (Gnosis S.p.A.)
Filter Reports
By Countries